Wednesday, March 18, 2020
Wilentz Health Law and Cannabis Co-Chair Michael F. Schaff will moderate the New Jersey State Bar Association Continuing Legal Education’s Second Annual Cannabis Symposium live webcast, presented in cooperation with the NJSBA Cannabis Law Special Committee. Mr. Schaff serves as co-chair of the Committee.
Wilentz health law and cannabis attorney Lisa Gora, who also serves as secretary of the NJSBA Committee, will discuss federal laws regulating food, beverages, cosmetics, unapproved new drugs, and dietary supplements containing cannabidiol (CBD). She will also review the warning letters issued by the U.S. Food and Drug Administration to cannabis companies for selling such products in ways that violate the federal Food, Drug, and Cosmetic Act.
The Symposium will cover the latest developments in the evolving laws surrounding cannabis use, sale, and growth, and their impacts on cannabis growers, distributers, sellers, and purchasers as well as practitioners in a wide variety of fields, including real estate, insurance, health law, zoning, criminal law, and municipal court. Significant updates to be discussed include the House Judiciary Committee’s approval of the Marijuana Opportunity Reinvestment and Expungement Act to decriminalize cannabis at the federal level and the 2020 referendum to amend the New Jersey Constitution and legalize recreational marijuana in New Jersey.
This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 6.7 hours of total CLE credit.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.